The San Diego, Calif.-based medical device company said the new operation will be headed by Takaaki Tanaka, its executive vice president for the Asia-Pacific region. Tanaka has been with the company since 2009, according to a press release.
"NuVasive’s formal presence in Tokyo is a testament to our commitment to surgeon customers and their patients in Japan. We look forward to improving patient outcomes with superior clinical results as we further introduce XLIF and our comprehensive spine portfolio to the Japanese market," Tanaka said in a statement.
Japan represents the second largest spine market in the world, according to NuVasive.